Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$56.4M |
| 2 |
Chemed
CHE
|
+$53.8M |
| 3 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$53.1M |
| 4 |
Petrobras
PBR
|
+$52.7M |
| 5 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMER
FIRSTMERIT CORP
FMER
|
+$58.7M |
| 2 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$38.2M |
| 3 |
PL
PROTECTIVE LIFE CORP
PL
|
+$37.8M |
| 4 |
Sally Beauty Holdings
SBH
|
+$36.2M |
| 5 |
TSMC
TSM
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.26% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.41% |
| 4 | Industrials | 7.4% |
| 5 | Consumer Discretionary | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIGY
1
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
| $1.44B | 3.08% |
11,784,588
-119,143
| -1% | -$15.3M |
|
|
2
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $1.28B | 2.73% |
10,830,699
+474,076
| +5% | +$56.4M |
|
3
Johnson & Johnson
JNJ
$617B
| $1.11B | 2.37% |
10,446,156
-2,292
| -0% | -$238K |
|
4
Apple
AAPL
$4.9T
| $1.08B | 2.31% |
42,964,740
-11,896
| -0% | -$292K |
|
5
American Express
AXP
$228B
| $997M | 2.13% |
11,387,462
+5,510
| +0% | +$496K |
|
|
FEEU
6
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
| $970M | 2.07% |
8,208,233
-89,703
| -1% | -$11.3M |
|
7
Wells Fargo
WFC
$258B
| $963M | 2.05% |
18,557,016
+7,278
| +0% | +$374K |
|
8
Pfizer
PFE
$142B
| $937M | 2% |
33,414,430
+231,887
| +0.7% | +$6.51M |
|
9
RTX Corp
RTX
$289B
| $885M | 1.89% |
13,318,188
+167,813
| +1% | +$11.5M |
|
10
Microsoft
MSFT
$3.35T
| $816M | 1.74% |
17,602,653
-84,869
| -0.5% | -$3.79M |
|
11
JPMorgan Chase
JPM
$933B
| $814M | 1.74% |
13,520,515
-57,169
| -0.4% | -$3.34M |
|
12
Alphabet (Google) Class C
GOOG
$4.08T
| $809M | 1.73% |
27,816,822
+55,713
| +0.2% | +$1.61M |
|
13
Amazon
AMZN
$2.53T
| $794M | 1.69% |
49,233,700
-95,400
| -0.2% | -$1.59M |
|
14
GE Aerospace
GE
$368B
| $789M | 1.68% |
6,427,117
+14,071
| +0.2% | +$1.75M |
|
15
Visa
V
$673B
| $766M | 1.63% |
14,355,408
+5,812
| +0% | +$312K |
|
16
Home Depot
HD
$332B
| $761M | 1.62% |
8,297,439
-66,425
| -0.8% | -$5.7M |
|
17
Berkshire Hathaway Class B
BRK.B
$1.1T
| $751M | 1.6% |
5,435,596
+17,743
| +0.3% | +$2.36M |
|
18
Walt Disney
DIS
$167B
| $750M | 1.6% |
8,427,622
-14,375
| -0.2% | -$1.27M |
|
19
Sanofi
SNY
$103B
| $742M | 1.58% |
13,145,647
+66,072
| +0.5% | +$3.55M |
|
20
Bank of America
BAC
$433B
| $722M | 1.54% |
42,362,278
+133,129
| +0.3% | +$2.12M |
|
21
Qualcomm
QCOM
$160B
| $695M | 1.48% |
9,301,782
+21,122
| +0.2% | +$1.62M |
|
22
Lloyds Banking Group
LYG
$90.7B
| $684M | 1.46% |
135,676,361
+1,148,631
| +0.9% | +$5.78M |
|
23
Intel
INTC
$460B
| $659M | 1.41% |
18,934,269
-30,193
| -0.2% | -$1.02M |
|
24
Comcast
CMCSA
$84B
| $655M | 1.4% |
24,343,864
-27,780
| -0.1% | -$761K |
|
25
HSBC
HSBC
$367B
| $638M | 1.36% |
14,562,827
+71,421
| +0.5% | +$3.25M |
|
Similar funds
Ken Fisher's Q3 2014 Portfolio in Review
As of Q3 2014, Ken Fisher held 645 positions worth $46.9B, down 1.4% from $47.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q3 2014 filing shows 47 new, 202 increased, 264 reduced and 61 closed positions. Its largest new stake was Chemed: 530,910 shares worth $54.6M. The largest sale was FIRSTMERIT CORP, an estimated $58.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q3 2014 buy was Chemed: 530,910 shares worth $54.6M.
- Ken Fisher added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2014, an estimated $56.4M increase.
- Ken Fisher's biggest Q3 2014 reduction was FIRSTMERIT CORP, cutting an estimated $58.7M.
- Ken Fisher fully exited PROTECTIVE LIFE CORP in Q3 2014, selling an estimated $37.8M.
- Ken Fisher's ten largest holdings make up 22% of its $46.9B portfolio in Q3 2014.
- Ken Fisher opened 47 new positions and closed 61 in Q3 2014.
- Ken Fisher's portfolio value fell 1.4% quarter-over-quarter to $46.9B.
Based on Fisher Asset Management's 13F filing for Q3 2014, filed 20 Oct 2014.